Literature DB >> 30611164

Anterior cervical spine surgery for the treatment of subaxial cervical spondylodiscitis: a report of 30 consecutive patients.

Benedikt W Burkhardt, Simon J Müller, Anne-Catherine Wagner, Joachim M Oertel.   

Abstract

OBJECTIVEInfection of the cervical spine is a rare disease but is associated with significant risk of neurological deterioration, morbidity, and a poor response to nonsurgical management. The ideal treatment for cervical spondylodiscitis (CSD) remains unclear.METHODSHospital records of patients who underwent acute surgical management for CSD were reviewed. Information about preoperative neurological status, surgical treatment, peri- and postoperative processes, antibiotic treatment, repeated procedure, and neurological status at follow-up examination were analyzed.RESULTSA total of 30 consecutive patients (17 male and 13 female) were included in this retrospective study. The mean age at procedures was 68.1 years (range 50-82 years), with mean of 6 coexisting comorbidities. Preoperatively neck pain was noted in 21 patients (70.0%), arm pain in 12 (40.0%), a paresis in 12 (40.0%), sensory deficit in 8 (26.7%), tetraparesis in 6 (20%), a septicemia in 4 (13.3%). Preoperative MRI scan revealed a CSD in one-level fusion in 21 patients (70.0%), in two-level fusions in 7 patients (23.3%), and in three-level fusions in 2 patients (6.7%). In 16 patients an antibiotic treatment was initiated prior to surgical treatment. Anterior cervical discectomy and fusion with cervical plating (ACDF+CP) was performed in 17 patients and anterior cervical corpectomy and fusion (ACCF) in 12 patients. Additional posterior decompression was performed in one case of ACDF+CP and additional posterior fixation in ten cases of ACCF procedures. Three patients died due to multiple organ failure (10%). Revision surgery was performed in 6 patients (20.7%) within the first 2 weeks postoperatively. All patients received antibiotic treatment for 6 weeks. At the first follow-up (mean 3 month) no recurrent infection was detected on blood workup and MRI scans. At final follow-up (mean 18 month), all patients reported improvement of neck pain, all but one patients were free of radicular pain and had no sensory deficits, and all patients showed improvement of motor strength. One patient with preoperative tetraparesis was able to ambulate.CONCLUSIONSCSD is a disease that is associated with severe neurological deterioration. Anterior cervical surgery with radical debridement and appropriate antibiotic treatment achieves complete healing. Anterior cervical plating with the use of polyetheretherketone cages has no negative effect of the healing process. Posterior fixation is recommended following ACCF procedures.

Entities:  

Keywords:  ACCF = anterior cervical corpectomy and fusion; ACDF = anterior cervical discectomy and fusion; ACDF+CP = ACDF with cervical plating; BMI = body mass index; CRP = C-reactive protein; CSD = cervical spondylodiscitis; ICU = intensive care unit; PEEK = polyetheretherketone; anterior cervical procedures; cervical spine; cervical spondylodiscitis; clinical outcome; epidural empyema; reoperation

Mesh:

Year:  2019        PMID: 30611164     DOI: 10.3171/2018.10.FOCUS18464

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  3 in total

1.  Thoracic spondylodiscitis secondary to Klebsiella oxytoca urosepsis-a case report.

Authors:  Christopher Alan Brooks; Sameer Mahajan; Rohan Beresford; Omprakash Damodaran; Raoul Pope
Journal:  J Spine Surg       Date:  2022-03

2.  Titanium versus polyetheretherketone versus structural allograft in anterior cervical discectomy and fusion: A systematic review.

Authors:  Jacob L Goldberg; Ross M Meaden; Ibrahim Hussain; Pravesh S Gadjradj; Danyal Quraishi; Fabian Sommer; Joseph A Carnevale; Branden Medary; Drew Wright; K Daniel Riew; Roger Hartl
Journal:  Brain Spine       Date:  2022-08-22

3.  Anterior Cervical Corpectomy and Fusion for Degenerative and Traumatic Spine Disorders, Single-Center Experience of a Case Series of 119 Patients.

Authors:  Charles Tatter; Oscar Persson; Gustav Burström; Erik Edström; Adrian Elmi-Terander
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-12-15       Impact factor: 2.703

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.